A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Clinical trial NCT02892812 · COMPLETED

Trial details

NCT number: NCT02892812
Sponsor: LG Life Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Infections

Start date: 2016-09-01
Primary completion: 2016-11-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.